Regenerative Medicine Market Propelled by Increasing Demand for Tissue Engineering and Stem Cell Therapy

Transparency Market Research has published a new report on the global regenerative medicine market. As per the report, the global regenerative medicine market stood at US$2.6 bn in 2012 and is predicted to reach US$6.5 bn by 2019. The report, titled ‘Regenerative Medicine Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019,’ states that the global regenerative medicine market is expected to expand at a 12.80% CAGR during the period from 2013 to 2019 due to factors such as technological innovations in biomaterials, the increasing prevalence of joint disorders, and the increasing number of orthopedic surgeries.

Regenerative medicines are an emerging field of medical science aimed at regeneration, repair, or replacement of damaged tissue and organs. As per the U.S. National Institute of Health, regenerative medicine is the procedure of creating functional tissues to repair and/or replace nonfunctional organs or tissues. With regenerative medicines, tissues or organs that have lost their functioning power due to congenital defects, age, and external or internal damage are repaired or replaced. Some of the application areas of regenerative medicines are neurology, cardiovascular, orthopedic, and musculoskeletal disorders.

Download Sample Brochure: http://bit.ly/1TfWHla

Factors such as technological advancements in stem cell therapy and tissue engineering are predicted to propel the global regenerative medicine market during the forecast period. However, ethical issues, post-implantation infections and complications, and regulatory constraints are expected to hamper the growth of the global regenerative medicine market in the years to come. Leading players are focusing on capturing the untapped market to increase their share in the global market. The high number of mergers, acquisitions, and partnerships expected to occur in the coming years is predicted to make the global regenerative medicine market highly competitive in the near future.

The global regenerative medicine market is segmented on the basis of technology, application, and geography. Based on geography, the global regenerative medicine market is divided into Asia Pacific, Europe, North America, and Rest of the World. In 2012, the global regenerative medicine market was dominated by North America due to the rising demand for bone and joint reconstructive surgeries. The region’s increasing aging population is predicted to propel the Europe regenerative medicine market in the next few years. Going forward, Asia Pacific is expected to register considerable growth in the global regenerative medicine market.

Companies such as DePuy Synthes, Inc. (HEALOS Bone Graft), Stryker Corporation (Vitoss Bone Graft Substitute), Zimmer Holdings, Inc. (CopiOs Bone Void Filler), and Medtronic, Inc. (INFUSE Bone Graft) are expected to lead the global regenerative medicine market in the years to come. The entry of new players is predicted to create new growth opportunities in the near future.

By technology, the global regenerative medicine market is classified into stem cell therapy, tissue engineering, and biomaterials. In 2012, the biomaterials segment dominated the global regenerative medicine market due to factors such as favorable reimbursement policies. Moreover, strong demand for biomaterials is predicted to propel the segment in the coming few years.

Browse Research with TOC & Free Analysis: http://bit.ly/1ZHXZWS

Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers.

Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com

This release was published on openPR.